Core Viewpoint - SelectQuote (NYSE: SLQT) faces a securities class action lawsuit following a significant drop in share price after the U.S. Department of Justice (DOJ) intervened in a lawsuit alleging illegal kickbacks and misleading business practices [1][4]. Group 1: Lawsuit Details - The class action lawsuit, Pahlkotter v. SelectQuote, Inc. et al., seeks to represent investors who acquired SelectQuote securities between September 9, 2020, and May 1, 2025 [1][2]. - The lawsuit focuses on SelectQuote's disclosures regarding its sales practices, particularly in its Senior business offering Medicare Advantage plans [2]. Group 2: Allegations Against SelectQuote - The DOJ's complaint alleges that from 2016 to at least 2021, SelectQuote received "tens of millions of dollars" in illegal kickbacks from health insurers for directing Medicare beneficiaries to specific plans [4]. - SelectQuote is accused of failing to provide unbiased comparisons of Medicare plans and instead directing beneficiaries to plans that compensated the company the most, regardless of quality [4][6]. - The company allegedly did not comply with applicable laws and regulations, making it vulnerable to sanctions, including violations of the federal False Claims Act [6]. Group 3: Impact on Share Price - Following the DOJ's announcement on May 1, 2025, SelectQuote's shares plummeted by 19% and have continued to decline amid ongoing legal challenges [1][5].

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years. I ...

Core Viewpoint - A securities class action lawsuit has been filed against SelectQuote, Inc. for allegedly misleading investors regarding its business practices and compliance with laws [1][2]. Allegations - The lawsuit claims that SelectQuote directed Medicare beneficiaries to insurers that compensated the company the most, regardless of the quality of the plans [2]. - It is alleged that SelectQuote did not provide unbiased comparisons for Medicare Advantage insurance plans and received illegal kickbacks from insurers [2]. - The company is accused of violating applicable laws and regulations, making it vulnerable to regulatory and legal sanctions, including claims under the False Claims Act [2][3]. Legal Developments - On May 1, 2025, the U.S. Department of Justice filed a False Claims Act complaint against SelectQuote, alleging the company received "tens of millions of dollars" in illegal kickbacks from health insurance companies from 2016 to at least 2021 [3]. - The DOJ's complaint states that SelectQuote made materially false claims about offering unbiased coverage comparisons while actually directing beneficiaries to the most profitable plans [3]. Market Reaction - Following the DOJ's announcement, SelectQuote's stock price dropped by $0.61, or 19.2%, closing at $2.56 per share on May 1, 2025 [3].

ATLANTA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against SelectQuote, Inc. ("SelectQuote" or the "Company") (NYSE: SLQT). The lawsuit alleges that: (1) that the Company was directing Medicare beneficiaries to the plans offered by insurers that best compensated SelectQuote, regardless of the quality or suitability of the insurers' plans; (2) that SelectQuote did not provided unbiased comparison shopping for Medicare Advantage insurance plans; (3) that SelectQuote r ...

SAN DIEGO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired SelectQuote, Inc. (NYSE: SLQT) securities between September 9, 2020 and May 1, 2025. SelectQuote is an insurance broker which sells Medicare Advantage and other health insurance plans online and by telephone. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP ...

Group 1 - The stock market has shown resilience by rallying to new highs despite previous concerns over tariffs [1] - Gary Alexander has extensive experience in technology sectors, both on Wall Street and in Silicon Valley, influencing his insights into current industry trends [1] - Alexander has been a contributor to Seeking Alpha since 2017, indicating a long-standing engagement with investment analysis [1] Group 2 - The article does not provide specific financial data or performance metrics related to any companies or sectors [2][3]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of SelectQuote, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Allegations and Impact - SelectQuote has been charged by the U.S. Department of Justice for allegedly paying illegal kickbacks to brokers from 2016 to 2021, which resulted in a significant stock price drop of 19.2% on May 1, 2025 [3]. - The investigation by Rosen Law Firm is a response to these allegations, indicating potential legal repercussions for SelectQuote and its shareholders [1][2]. Group 2: Class Action Information - Shareholders who purchased SelectQuote securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2]. - Interested investors can join the class action by submitting a form or contacting the law firm directly for more information [2]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [4]. - The firm has recovered hundreds of millions of dollars for investors, with notable achievements including over $438 million secured in 2019 alone [4].

Core Viewpoint - SelectQuote (SLQT) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook on its earnings estimates, which is a significant factor influencing stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the importance of changing earnings estimates, which are strongly correlated with near-term stock price movements [4][6]. - Institutional investors often rely on earnings estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [4]. SelectQuote's Earnings Outlook - The recent upgrade for SelectQuote reflects an improvement in its underlying business, driven by rising earnings estimates, which is expected to create buying pressure and increase its stock price [5][10]. - Over the past three months, the Zacks Consensus Estimate for SelectQuote has increased by 33.3%, indicating a positive trend in earnings expectations [8]. Zacks Rank System - The Zacks Rank system classifies stocks based on earnings estimate revisions, with a proven track record of generating significant returns, particularly for Zacks Rank 1 stocks [7]. - Only the top 20% of Zacks-covered stocks receive a "Strong Buy" or "Buy" rating, positioning SelectQuote favorably for potential market-beating returns [9][10].

Company Overview - SelectQuote, Inc. (SLQT) operates as a technology-enabled, direct-to-consumer platform that connects U.S. consumers with various insurance products across senior health, life, auto, and home markets [1] Research Approach - Moretus Research provides high-quality equity research focused on U.S. public markets, utilizing a structured framework to identify companies with durable business models and mispriced cash flow potential [1] - The research emphasizes rigorous fundamental analysis combined with a judgment-driven process, avoiding noise and overly complex forecasting [1] - Valuation methods are based on sector-relevant multiples tailored to each company's business model and capital structure, prioritizing comparability and simplicity [1] Investment Focus - Moretus Research tends to favor underappreciated companies undergoing structural changes or temporary dislocations, where dispassionate analysis can lead to asymmetric returns [1] - The research reflects a commitment to capital discipline and long-term compounding, aiming to elevate the standard for independent investment research [1]

Core Viewpoint - SelectQuote Inc. is facing significant investor pressure due to disappointing quarterly results and ongoing legal issues, leading to a substantial decline in its stock price [1][3]. Financial Performance - For the quarter ended March 2025, SelectQuote reported earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share [2]. - The company posted revenues of $408.16 million, falling short of the Zacks Consensus Estimate of $417.01 million by 2.12% [2]. Legal Issues - The U.S. Department of Justice (DOJ) announced a lawsuit against SelectQuote and several major health insurers on May 1, 2025, alleging violations of the False Claims Act related to the marketing of Medicare Advantage plans [3][4]. - The lawsuit claims that from 2016 to at least 2021, SelectQuote and other brokers were incentivized to steer beneficiaries toward high-commission plans, potentially disregarding the suitability of those plans [4]. Investor Sentiment - The combination of a weaker-than-expected earnings report and serious legal allegations has heightened concerns regarding SelectQuote's financial stability and operational integrity [5]. - Hagens Berman is investigating potential violations of U.S. securities laws and is encouraging investors who suffered losses to come forward [2][5].